Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-212336
Filing Date
2012-05-04
Accepted
2012-05-04 17:18:07
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d343445d10q.htm 10-Q 241712
2 EX-31.1 d343445dex311.htm EX-31.1 10260
3 EX-31.2 d343445dex312.htm EX-31.2 10270
4 EX-32.1 d343445dex321.htm EX-32.1 4519
  Complete submission text file 0001193125-12-212336.txt   1280803

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpix-20120331.xml EX-101.INS 94492
6 XBRL TAXONOMY EXTENSION SCHEMA cpix-20120331.xsd EX-101.SCH 11046
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpix-20120331_cal.xml EX-101.CAL 30210
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpix-20120331_def.xml EX-101.DEF 9329
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpix-20120331_lab.xml EX-101.LAB 113130
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpix-20120331_pre.xml EX-101.PRE 70260
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 12815302
SIC: 2834 Pharmaceutical Preparations